Neoleukin Therapeutics
Biotechnology
Healthcare
NLTX
56.16 M shares
NASDAQ US
traded
18 Dec 2023
listed
no
open
3.45
52 week high
9.09
high
3.59
52 week low
1.33
low
3.42
growth
-11.65 %
previous Close
3.44
P/E ratio
market cap
29.49 M
div yield
0
usd
Jun 2023
qoq
revenue
0.00 %
net incoming
-2.09 M
0.00 %
eps
0.00 %
83.33 %
eps surprise
0.00 %
net profit margin
-208500000.00 %
0.00 %
operating incoming
-3.07 M
0.00 %
net change in cash
-4.75 M
0.00 %
cash on hand
31.11 M
0.00 %
cost of revenue
0.00 %
top top